Bill > HF4852

This bill modifies the rules for the Formulary Committee, which advises on which prescription drugs are covered by Minnesota's medical assistance program. It allows members of the committee who have a potential conflict of interest, meaning they might benefit financially from a decision, to still participate in discussions and communications, though they must publicly disclose these conflicts and the commissioner of human services must post this information online at least 48 hours before a meeting where the drug in question is discussed. The bill also requires the commissioner to create a public comment process for recommendations made to the committee and mandates that the committee actively seek expertise from the Minnesota Rare Disease Advisory Council, especially concerning drugs for rare diseases or those requiring prior authorization, which is a process to get approval before a drug is covered. Additionally, the bill extends the expiration date of the Formulary Committee and streamlines the prior authorization process for certain liquid medications used by patients with feeding tubes.

Health and Social Services

https://www.revisor.mn.gov/bills/94/2026/0/HF/4852/